Single-Center Incidence and Patterns of Stroke in Early Renal Anhydramnios After Serial Amnioinfusions
- PMID: 38615944
- PMCID: PMC11239294
- DOI: 10.1016/j.jpeds.2024.114053
Single-Center Incidence and Patterns of Stroke in Early Renal Anhydramnios After Serial Amnioinfusions
Abstract
The Renal Anhydramnios Fetal Therapy (RAFT) trial is a study of serial amnioinfusions to prevent lethal neonatal pulmonary hypoplasia from early renal anhydramnios. Infant neurologic outcomes were not originally evaluated. We describe the high incidence of stroke observed among infants in the treatment arm of the trial at our center.
Keywords: cerebral ischemia; dysplastic kidney; renal agenesis.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors have no conflicts of interest to disclose. Funding for the Renal Anhydramnios Fetal Therapy (RAFT) Trial is provided by RO1 HD100540 from the National Institutes of Child Health and Development (NICHD; authors JLM and MAA co-PI). The NICHD had no role in the design and conduct of the study. Publication of this data was approved by the Data Safety Monitoring Board (DSMB). Renal Anhydramnios Fetal Therapy (RAFT) is listed on ClinicalTrials.gov, identifier NCT03101891. Deidentified individual participant data will not be made available.
Figures
References
-
- Felling RJ, Sun LR, Maxwell EC, Goldenberg N, Bernard T. Pediatric arterial ischemic stroke: Epidemiology, risk factors, and management. Blood Cells Mol Dis. 2017;67:23–33. - PubMed
-
- Srivastava R, Kirton A. Perinatal Stroke: A Practical Approach to Diagnosis and Management. Neoreviews. 2021;22(3):e163–e76. - PubMed
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
